NCT02102633View on ClinicalTrials.gov

Drug Interaction Study Between Bosutinib And Dabigatran

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Dabigatran

Dabigatran 150 mg orally

DRUG

Bosutinib

Bosutinib 500 mg orally

DRUG

Dabigatran

Dabigatran 150 mg orally

Trial Locations (1)

32720

Pfizer Investigational Site, DeLand

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02102633 - Drug Interaction Study Between Bosutinib And Dabigatran | Biotech Hunter | Biotech Hunter